ArticleReproduction & fertility2026
A multifactorial analysis of in vitro fertilization outcomes.
Article in Reproduction & fertility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and external validation of a three-stage model to predict live birth after fresh IVF/ICSI embryo transfer.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abstract: Outcomes of in vitro fertilization (IVF) are woven by a complex interplay of multiple factors. Identifying how various variables correlate with the outcome of each step during the IVF procedure can inform on the overall success of the procedure. We studied 1,736 non-donor IVF cycles at our fertility center to evaluate associations between maternal age, body mass index (BMI), anti-Müllerian hormone (AMH) level, and antral follicle count (AFC) with the overall success of IVF in the first cycle, subsequent cycles, and all cycles, defined in terms of oocytes retrieved, oocyte maturation rate, fertilization rate, and live birth. The results indicated that maternal age was the strongest factor in IVF success with live birth rate of 57, 41, and 53% in the first cycle, subsequent cycles, and all cycles, respectively, in women < 35 years, and 27, 16, and 22% in the first cycle, subsequent cycles, and all cycles, respectively, in women 41-42 years old. AMH levels and AFC were strongly associated with oocyte retrieval and blastocyst formation but were less associated with the live birth. The number of mature oocytes and oocyte maturation rates were significantly associated with live birth. BMI did not show a significant correlation with oocyte yield and embryo development except in extremely obese patients. These findings support the use of individualized treatment strategies and development of predictive modeling based on biological markers to optimize IVF success. Lay summary: This study analyzed the data collected from the patients undergoing IVF to investigate the association between maternal age, anti-Müllerian hormone (AMH) - a protein hormone produced by the cells surrounding the developing eggs - levels, antral follicle count (AFC) - a measure of ovarian reserve or potential fertility, and BMI, and key reproductive outcomes including retrieved eggs, maturation rate, embryo development rate, and live birth. An analysis of multiple factors and IVF outcomes showed that maternal age remains the most significant factor of the IVF success. Although AMH and AFC are strong markers of ovarian response, their association with live birth is limited. Additionally, BMI did not show a significant impact on the outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.